
News|Articles|February 8, 2024
mAb Characterization Process Innovations
Author(s)SCIEX
Earlier assessment of molecules provides valuable insights into the manufacturing developability of molecules, reducing the need for unnecessary experimentation. The Intabio ZT system has the potential to make in-depth characterization of biopharmaceutical product charge variants quicker and more efficient to meet demanding timelines during early-phase clinical development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5